Abstract
A high-fat diet increases the risk of colon, breast and prostate cancer. The molecular mechanism by which dietary lipids promote tumorigenesis is unknown. Their effects may be mediated at least in part by the peroxisome proliferator-activated receptors (PPARs). These ligand-activated nuclear receptors modulate gene expression in response to fatty acids, lipid-derived metabolites and antidiabetic drugs. To explore the role of the PPARs in diet-induced carcinogenesis, we treated mice predisposed to intestinal neoplasia with a synthetic PPARγ ligand. Reflecting the pattern of expression of PPARγ in the gastrointestinal tract, treated mice developed a considerably greater number of polyps in the colon but not in the small intestine, indicating that PPARγ activation may provide a molecular link between a high-fat diet and increased risk of colorectal cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
206,07 € per year
only 17,17 € per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout




Similar content being viewed by others
References
The World Health Organization in The World Health Report (World Health Organization, Geneva, 1997).
Weisburger, J. H. Dietary fat and risk of chronic disease: mechanistic insights from experimental studies. J. Am. Diet. Assoc. 97 (suppl.) S16–S23 (1997).
Giovannucci, E. & Goldin, B. The role of fat, fatty acids, and total energy intake in the etiology of human colon cancer. Am. J. Clin. Nutr. 66 (suppl.) 1564S– 1571S (1997).
Reddy, B. S., Tanaka, T. & Simi, B. Effect of different levels of dietary trans fat or corn oil on azoxymethane-induced colon carcinogenesis in F344 rats. J. Natl. Cancer Inst. 75, 791–798 (1985).
Reddy, B. S., Burill, C. & Rigotty, J. Effects of diets high in ω-3 and ω-6 fatty acids on initiation and postinitiation stages of colon carcinogenesis. Cancer Res. 51, 487–491 (1991).
Hioki, K. et al. Suppression of intestinal polyp development by low-fat and high-fiber diet in ApcΔ716 knockout mice. Carcinogenesis 18, 1863–1865 ( 1997).
Reddy, B. S. & Sugie, S. Effect of different levels of omega-3 and omega-6 fatty acids on azoxymethane-induced colon carcinogenesis in F344 rats. Cancer Res. 48, 6642– 6647 (1988).
Klurfled, D. M. & Bull, A. W. Fatty acids and colon cancer in experimental models. Am. J. Clin. Nutr. 66 (suppl.) 1530S–1538S ( 1997).
Mangelsdorf, D. J. et al. The nuclear receptor superfamily: the second decade. Cell 83, 835–841 (1995).
Kliewer, S. A. et al. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc. Natl. Acad. Sci. USA 91, 7355–7359 (1994).
Dreyer, C. et al. Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors. Cell 68, 879–887 (1992).
Tontonoz, P., Hu, E. & Spiegelman, B. M. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell 79, 1147–1156 (1994).
Forman, B. M. et al. M. 15-deoxy-Δ12,1―prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ. Cell 83, 803–812 (1995).
Kliewer, S. A. et al. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell 83, 813–819 (1995).
Forman, B. M., Chen, J. & Evans, R. M. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ. Proc. Natl. Acad. Sci. USA 94, 4312–4317 (1997).
Kliewer, S. A. et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ. Proc. Natl. Acad. Sci. USA 94, 4318–4323 (1997).
Kargman, S. L. et al. Expression of prostaglandin G/H synthetase-1 and -2 protein in human colon cancer. Cancer Res. 55, 2556 –2559 (1995).
Sano, H. et al. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res. 55, 3785–3789 (1995).
Oshima, M. et al. Suppression on intestinal polyposis in ApcΔ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87, 803–809 (1996).
Singh, J., Hamid, R. & Reddy, B. S. Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis. Cancer Res. 57, 3465– 3470 (1997).
Moser, A. R. et al. ApcMin: a mouse model for intestinal and mammary tumorigenesis. Eur. J. Cancer 31A, 1061–1064 (1995).
Cantello, B. C. C. et al. [[ω-(Heterocyclyamino)alkoxy]benzyl]-2,4-thiazolidinediones as potent antihyperglycemic agents. J. Med. Chem. 37 , 3977–3985 (1994).
Lehmann, J. M. et al. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ). J. Biol. Chem. 270, 12953– 12956 (1995).
Lefebrvre, A.-M. et al. Activation of the peroxisome proliferator-activated receptor (promotes the development of colon tumors in C57BL/6J-APCMin/+ mice. Nature Med. 4, XXX-XXX (1998).
DuBois, R. N. et al. The nuclear eicosanoid receptor, PPARγ, is aberrantly expressed in colonic cancers. Carcinogenesis, 19, 49–53 (1998).
Reddy, B. S. & Maeura, Y. Tumor promotion by dietary fat in azoxymethane-induced colon carcinogenesis in female F344 rats: influence of amount and source of dietary fat. J. Natl. Cancer Inst. 72, 745–750 (1984).
Temple, N. J. & El-Khatib, S. M. Effect of high fat and nutrient depleted diets on colon tumor formation in mice. Cancer Lett. 37, 109–114 (1987).
Hogan, M. L. & Shamsuddin, A. M. Large intestinal carcinogenesis. I. Promotional effect of dietary fatty acid isomers in the rat model. J. Natl. Cancer Inst. 73, 1293–1296 (1984).
Wasan, H. S., Novelli, M., Bee, J. & Bodmer, W. F. Dietary fat influences on polyp phenotype in multiple intestinal neoplasia mice. Proc. Natl. Acad. Sci. USA 94, 3308– 3313 (1997).
Oshima, M. et al. Effects of docosahexaenoic acid (DHA) on intestinal polyp development in ApcΔ716 knockout mice. Carcinogenesis, 16, 2605–2607 (1995).
Tontonoz, P., Nagy, L., Alvarez, J. G. A., Thomazy, V. A. & Evans, R. M. PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell, 93 , 241–252 (1998).
Tontonoz, P. et al. Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor γ and the retinoid X receptor. Proc. Natl. Acad. Sci. USA 94, 237–241 (1997).
Mueller, E. et al. Terminal differentiation of human breast cancer through PPARγ. Molecular Cell 1, 465– 470 (1998).
Berger, J. et al. Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-γ: binding and activation correlate with antidiabetic actions in db/db mice. Endocrinology 137, 4189–4501 (1996).
Kinzler, K. W. & Vogelstein, B. Lessons from hereditary colorectal cancer. Cell 87, 159 –170 (1996).
Acknowledgements
Troglitazone was a gift from Sankyo Co.LTD. We thank R. Boland, R. Kucherlapati, R. Kolodner, G. Wahl, R. Heyman and J. Auwerx for discussions, and B. Gilpin for statistical analysis. R.M.E. is an Investigator of the Howard Hughes Medical Institute at the Salk Institute for Biological Studies. E.S. is a fellow of the Susan G. Komen Breast Cancer Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Saez, E., Tontonoz, P., Nelson, M. et al. Activators of the nuclear receptor PPARγ enhance colon polyp formation. Nat Med 4, 1058–1061 (1998). https://doi.org/10.1038/2042
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/2042